ELX-02 Reduces Sweat Chloride in Patients with G542X Mutation. Trials Find

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/rtvnnet/websites-directory.com/wp-includes/functions.php on line 6114
ELX-02 Reduces Sweat Chloride in Patients with G542X Mutation. Trials Find - Website Directory

ELX-02 Reduces Sweat Chloride in Patients with G542X Mutation. Trials Find

zuclichwolf0328 November 21, 2021

Software

cystic fibrosis

http://disorders.solutions/cystic-fibrosis/elx02-reduces-sweat-chloride-in-patients-with-g542x-mutation-trials-find

Eloxx PharmaceuticalsҠexperimental therapy ELX-02 was generally safe and resulted in a significant reduction in sweat chloride levels נa biomarker..